You can't rely on whytee to provide any specific information.He treats requests for more information like he is being interrogated.
Fortunately for us MSB has provided responses that have are initially assessed as complete by the FDA.
Whytee McStuffin's concerns are currently irrelevant. Who knows, that might change if another CRL is issued, but there is currently no public information to suggest that is the case.Their irrelevant musings are just biased opinions and assumptions.
Cell Therapy News/Articles, page-16466
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.050(4.46%) |
Mkt cap ! $1.224B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.04 | $7.764M | 7.215M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 69401 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 141609 | 19 |
View Market Depth
| Last trade - 12.00pm 09/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |